Operating Profit Veränderung Datum
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Alterity Therapeutics Limited AUD -7772080 2.99M 2023-06
Amgen USD 1.27B 819M 2023-12
Baxter International USD 299M 350M 2023-12
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Biogen USD 358.9M 200.1M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Cara Therapeutics USD -28898000 3.44M 2023-09
Cipla INR 14.44B 1.89B 2023-09
Dr.Reddys Laboratories INR 16.77B 316M 2023-09
Eisai JPY 5.4B 20.63B 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Exelixis USD -17583000 95.43M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Grifols EUR 250.59M 7.19M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Incyte USD 187.27M 27.44M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Ironwood Pharmaceuticals USD 37.59M 2.43M 2023-12
Merck USD -1933000000 7.68B 2023-12
Nektar Therapeutics USD -44864000 5.74M 2023-09
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Takeda JPY -49342000000 217.91B 2023-09
Teva Pharmaceutical Industries USD 355M 1B 2023-09
Xencor USD -35009000 16.74M 2023-12



Nektar Therapeutics Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.